Research news

Joan Montero and colleagues in Boston suggest a new strategy for melanoma patients

IBEC researcher Joan Montero authors a paper in Nature Communications which uncovers a key adaptation that melanoma cancer cells use to evade current therapies. This finding might allow physicians to use better drug combinations to improve patient outcomes in the future.

Despite significant advances in cancer diagnosis and treatment, most targeted cancer therapies fail to achieve complete tumor regressions or durable remission. Understanding why these treatments are not always efficient has remained a main challenge for researchers and physicians. Now, Joan Montero from the IBEC and colleagues at Dana-Farber Cancer Institute/Harvard Medical School in USA report in Nature Communications a mechanism that uncovers why some therapies fail to treat melanoma.

Read more…

Other news

The Congress of the Spanish Society of Biomedical Engineering brings together more than 200 researchers with the slogan “For a Personalised and Universal Health”

Raimon Jané, President of the Spanish Society of Biomedical Engineering (SEIB), Group Leader of the Bioengineering Institute of Catalonia (IBEC) and CIBER-BBN, inaugurated the conference with the Health Minister of the Government of Cantabria, the Dean of the University of Cantabria, the Director of the Hospital and the President of the CASEIB2019 Organising Committee.

Read more…